3.Different roles played by periostin splice variants in retinal neovascularization. Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Abe T, Kiyonari H, Shioi G, Katsuragi N, Ishibashi T, Morishita R, Taniyama Y; Exp Eye Res. 153:133-40, 2016/12/01
4.Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Satoh M, Namba KI, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, Onoe K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda KH, Van kaer L, Iwabuchi K; Exp Eye Res. 153:79-89, 2016/12/01
5.Changes in chorioretinal blood flow velocity and cerebral blood flow after endarterectomy. Enaida H, Nagata S, Takeda A, Nakao S, Ikeda Y, Ishibashi T; Jpn J Ophthalmol. 60:459-465, 2016/11/01
7.Ocular Behçet's disease is less complicated with allergic disorders. A nationwide survey in Japan. Horie Y, Kitaichi N, Hijioka K, Sonoda KH, Saishin Y, Kezuka T, Goto H, Takeuchi M, Nakamura S, Kimoto T, Shimakawa M, Kita M, Sugita S, Mochizuki M, Hori J, Iwata M, Shoji J, Fukuda M, Kaburaki T, Numaga J, Kawashima H, Fukushima A, Joko T, Takai N, Ozawa Y, Meguro A, Mizuki N, Namba K, Ishida S, Ohno S; Clin Exp Rheumatol. 102:111-4, 2016/10/25
9.Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population. Momozawa Y, Akiyama M, Kamatani Y, Arakawa S, Yasuda M, Yoshida S, Oshima Y, Mori R, Tanaka K, Mori K, Inoue S, Terasaki H, Yasuma T, Honda S, Miki A, Inoue M, Fujisawa K, Takahashi K, Yasukawa T, Yanagi Y, Kadonosono K, Sonoda KH, Ishibashi T, Takahashi A, Kubo M; Hum Mol Genet. 25(22):5027-34, 2016/10/03
10.Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV Kobayashi Y, Yoshida S, Zhou Yedi, Nakama T, Ishikawa K, Kubo Y, Arima M, Nakao S, Hisatomi T, Ikeda Y, Matsuda A, Sonoda KH, Ishibashi T; Lab Invest. 96:1178–88, 2016/09/26
15.Inhibition by all-trans retinoic acid of collagen degradation mediated by corneal fibroblasts. Kimura K, Zhou H, Orita T, Kobayashi S, Wada T, Nakamura Y, Nishida T, Sonoda KH; Clin Exp Ophthalmol. 44:502-8, 2016/08/01
16.Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2 Taher M, Nakao S, Zandi S, Melhorn MI, Hayes KC, Hafezi-Moghadam A; FASEB J. 30:2490-2499, 2016/07/30
17.Changes in metabolic proteins in ex vivo rat retina during glutamate-induced neural progenitor cell induction Tokuda K, Kuramitsu Y, Baron B, Kitagawa T, Tokuda N, Kobayashi M, Kimura K, Sonoda KH, Nakamura K; Mol Cell Biochem. 419:177-84, 2016/07/15
19.Cataracts after Low-Dose Radiotherapy for Lymphoproliferative Disease of the Ocular Adnexa Hashimoto S, Yoshikawa H, Onishi Y, Miyagi M; Semin Ophthalmol. 15:1-5, 2016/07/01
20.Comparison of Intravitreal Ranibizumab on Diabetic Macular Edema in Vitrectomized and Nonvitrectomized Eyes Koyanagi Y, Yoshida S, Kobayashi Y, Kubo Y, Yamaguchi M, Nakama T, Nakao S, Ikeda Y, Oshima Y, Ishibashi T, Sonoda KH; Ophthalmologica. 236:67-73, 2016/07/01
22.Coordinated Regulation of Palladin and α-Smooth Muscle Actin by Transforming Growth Factor-β in Human Corneal Fibroblasts. Morishige N, Murata S, Nakamura Y, Azumi H, Shin-Gyou-Uchi R, Oki KT, Morita Y, Sonoda KH; Invest Ophthalmol Vis Sci. 57:3360-3308, 2016/06/01
23.Foveal and Macular Thickness in a Japanese Population: The Hisayama Study Hashimoto S, Yasuda M, Ishibashi T, Tahara T, Arakawa S, Fujiwara K; Ophthalmic Epidemiol. 23:202-8, 2016/06/01
24.The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy. Sassa Y, Yoshida S, Ishikawa K, Asato R, Ishibashi T, Kono T; Eye (Lond). 30:746-53, 2016/05/16
25.Differential Changes in Intraocular Pressure and Corneal Manifestations in Individuals With Viral Endotheliitis After Keratoplasty. Morishige N, Morita Y, Yamada N, Sonoda KH; Cornea. 35:602-6, 2016/05/01
27.Combination management by C-arm fluoroscopy and extraocular muscle severance for penetrating ocular trauma with a retrobulbar foreign body. Hatano M, Kimura K, Nomi N, Teranishi S, Orita T, Fujitsu Y, Sonoda KH; Orbit. 35:167-9, 2016/04/12
28.Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia Yamaguchi M, Nakao S, Arita R, Kaizu Y, Arima M, Zhou Yedi, Kita T, Yoshida S, Kimura K, Isobe T, Kaneko Y, Sonoda KH, Ishibashi T; Invest Ophthalmol Vis Sci. 57:2264-76, 2016/04/01
31.Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses. Sakoda Y, Nagai T, Murata S, Mizuno Y, Kurosawa H, Shoda H, Morishige N, Yanai R, Sonoda KH, Tamada K; J lmmunol. 196:2947-54, 2016/02/24
32.Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy. Zhou Y, Yoshida S, Kubo Y, Kobayashi Y, Nakama T, Yamaguchi M, Ishikawa K, Nakao S, Ikeda Y, Ishibashi T, Sonoda KH; Sci Rep. 6:28140, 2016/01/17
33.Possibility of Müller Cell Dysfunction as the Pathogenesis of Paclitaxel Maculopathy Nakao S, Ikeda Y, Emi Y, Ishibashi T; Ophthalmic Surg Lasers Imaging Retina. 47:81-84, 2016/01/05
1.The Corneal Micropocket Assay: A Model of Angiogenesis and Lymphangiogenesis Nakao S, Hafezi-Moghadam A; Angiogenesis Protocols. 1430:311-6, 2016/05/13
1.Intravitreal Aflibercept in Wet Age-Related Macular Degeneration Patients From Japan: Interim 6-Month Outcomes of J-PMS Oshima Y, Mori R, Ohji M, Ishibashi T; The 10th Congress of the Asia-Pacific Vitreo-Retina Society (APVRS), Bangkok,Thailand , 2016/12/09
2.Phase I clinical study for patients with retinitis pigmentosa: report of low-titer group Ikeda Y, Murakami Y, Nakatake S, Tachibana T, Miyazaki M, Yonemitsu Y, Inoue M, Enaida H, Ishibashi T, Sonoda KH; European Society for Gene and Cell Therapy 2016, Florence,Italy, 2016/10/19
3.C-Reactive Protein and Progression of Vision Loss in Retinitis Pigmentosa Murakami Y, Ikeda Y, Nakatake S, Fujiwara K, Tachibana T, Hisatomi T, Yoshida S, Ishibashi T, Sonoda KH; American Academy of Ophthalmology, Chicago,USA, 2016/10/17
4.The non-contact meibography findings of 2 cases of sebaceous adenoma of eyelid Takagi K, Yoshikawa H, Tanabe M, Fujikawa K, Arita R, Akiyama M, Shiose S, Sonoda KH; Pathology of meibomian glands Sattelite meetings of 20th ISER, Wakayama,Japan, 2016/09/24
5.Impact of Anti-VEGF Therapy on Photoreceptor in Patients with Exudative Age-Related Macular Degeneration Nakao S, Oshima Y, Kaizu Y, Yamaguchi M, Yoshida S, Ishibashi T, Sonoda KH; 49th Annual Retina Society Meeting, San Diego,USA, 2016/09/16
6.Association between aqueous flare and epiretinal membrane in Retinitis Pigmentosa Fujiwara K, Ikeda Y, Nakatake S, Murakami Y, Tachibana T, Nakao S, Yoshida N, Hisatomi T, Yoshida S, Yoshitomi T, Sonoda KH, Ishibashi T; The 9th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists, Suzhou,China, 2016/09/10
7.Comparison of Adaptive Optics Scanning Laser Ophthalmoscopy and Optical Coherence Tomography Angiography in ability to visualize retinal microvasculature in the healthy eye Kaizu Y, Nakao S, Yamaguchi M, Wada I, Fujiwara K, Yoshida S, Ishibashi T, Sonoda KH; The 9th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists, Suzhou,China, 2016/09/10
8.Detection of airbag impact-induced cone photoreceptor damage by adaptive optics scanning laser ophthalmoscopy: a case report Wada I, Kaizu Y, Nakao S, Yamaguchi M, Murakami Y, Ishibashi T, Sonoda KH; The 9th Joint Meeting of CJK Ophthalmologists, Suzhou,China, 2016/09/10
9.Differential Association of Elevated Inflammatory Cytokines with Postoperative Fibrous Proliferation and Neovascularization after Vitrectomy in Eyes with Proliferative Diabetic Retinopathy Yoshida S, Kubo Y, Kobayashi Y, Nakama T, Ishikawa K, Nakao S, Sassa Y, Hisatomi T, Ikeda Y, Oshima Y, Kohno T, Ishibashi T, Sonoda KH; The 9th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists, Suzhou,China, 2016/09/10
10.Incomplete recovery of retinal structure after vitrectomy with internal limiting membrane peeling Hisatomi T, Tachibana T, Notomi S, Murakami Y, Ikeda Y, Yoshida S, Oshima Y, Enaida H, Murata T, Sakamoto T, Sonoda KH, Ishibashi T; The 9th Joint Meeting of China-Japan-Korea Ophthalmologists, Suzhou, China, 2016/09/10
11.MUTYH promotes oxidative microglial activation and neurodegeneration in a mouse model of retinitis pigmentosa Nakatake S, Murakami Y, Ikeda Y, Tachibana T, Hisatomi T, Yoshida S, Nakabeppu Y, Ishibashi T, Sonoda KH; The 9th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists, Suzhou,China, 2016/09/10
12.Neuroprotective gene therapy for patients with retinitis pigmentosa: interim report of low-titer group Ikeda Y; The 9th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists, Suzhou, China, 2016/09/10
13.Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV Kobayashi Y, Yoshida S, Kubo Y, Zhou Yedi, Nakama T, Ishikawa K, Arima M, Nakao S, Hisatomi T, Ikeda Y, Matsuda A, Sonoda KH, Ishibashi T; The 9th Joint Meeting of JAPAN-CHINA-KOREA Ophthalmologists, Suzhou,China, 2016/09/10
14.The non-contact meibography findings of 2 cases with sebaceous adenoma of eyelid Takaki Ken-ichi, Yoshikawa H, Tanabe M, Fujikawa K, Shiose S, Arita R, Akiyama M, Sonoda KH; 9th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists, Suzhou,China, 2016/09/10
15.Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia Yamaguchi M, Nakao S, Arita R, Kaizu Y, Arima M, Zhou Yedi, Kita T, Yoshida S, Kimura K, Isobe T, Kaneko Y, Ishibashi T, Sonoda KH; The 9th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists, Suzhou, China, 2016/09/10
16.Interleukin-12 regulates hypoxia-induced retinal neovascularization in mice Zhou Yedi, Yoshida S, Kubo Y, Kobayashi Y, Nakama T, Yamaguchi M, Ishikawa K, Nakao S, Ikeda Y, Ishibashi T, Sonoda KH; 第20回眼科創傷治癒研究会, 福岡県, 2016/08/20
17.Association between aqueous flare and epiretinal membrane in retinitis pigmentosa Ikeda Y, Fujiwara K, Murakami Y, Nakatake S, Tachibana T, Nakao S, Hisatomi T, Oshima Y, Yoshida S, Ishibashi T, Sonoda KH; 34th Annual Meeting of The American Society of Retina Specialists 2016, San Francisco,USA, 2016/08/10
18.Two-year outcomes following intravitreal aflibercept for polypoidal choroidal vasculopathy in Japanese patients. Oshima Y, Shiose S, Yasuda M, Kano K, Nakao S, Yoshida S, Ishibashi T, Sonoda KH; American Society of Retina Specialists 34th Annual Meeting,, San Francisco, USA, 2016/08/09
19.Necrotic Enlargement of Cone Photoreceptor Cells and the Release of High-Mobility Group Box-1 in Retinitis Pigmentsa Murakami Y, Ikeda Y, Nakatake S, Miller J, Vavvas D, Ishibashi T, Sonoda KH; International Cell Death Society, Cork,Ireland, 2016/06/03
20.Altered concentrations of soluble CD163 in the vitreous of patients with proliferative diabetic retinopathy after vitrectomy Kubo Y, Yoshida S, Kobayashi Y, Zhou Yedi, Nakama T, Ishikawa K, Nakao S, Sassa Y, Kohno T, Sonoda KH; ARVO, Seattle,USA, 2016/05/05
21.Inhibition of choroidal neovascularization by siRNA targeting tenascin-C Kobayashi Y, Yoshida S, Kubo Y, Zhou Yedi, Nakama T, Ishikawa K, Nakao S, Oshima Y, Matsuda A, Ishibashi T, Sonoda KH; ARVO, Seattle,USA, 2016/05/04
22.Vitreous and subretinal fluid ATP concentrations in rhegmatogenous retinal detachment Tachibana T, Hisatomi T, Notomi S, Nakatake S, Murakami Y, Sengoku A, Ikeda Y, Yoshida S, Ishibashi T, Sonoda KH; ARVO, Seattle,USA, 2016/05/04
23.Clinical Features of Systemic Metastatic Retinal Lymphoma in Japanese Patients Taki R, Takeda A, Yoshikawa H, Fukuhara T, Arita R, Suehiro Y, Choi I, Ishibashi T, Sonoda KH; ARVO, Seattle,USA, 2016/05/03
24.One-year Outcomes following Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in Japanese Patients: The APOLLO study Oshima Y, Kimoto K, Yoshida N, Fujisawa K, Sonoda S, Kubota T, Murata T, Sakamoto T, Sonoda KH, Ishibashi T; ARVO, Seattle, USA, 2016/05/03
25.Comparison of Intravitreal Ranibizumab on Diabetic Macular Edema in Vitrectomized and Nonvitrectomized Eyes Koyanagi Y, Yoshida S, Kobayashi Y, Kubo Y, Yamaguchi M, Nakama T, Nakao S, Ikeda Y, Oshima Y, Ishibashi T, Sonoda KH; ARVO, Seattle,USA, 2016/05/02
26.Oxidative DNA Damage in Microglia Exacerbates Retinal Inflammation and Degeneration through MUTYH-mediated Base Excision Repair in a Mouse Model of Retinitis Pigmentosa Nakatake S, Murakami Y, Ikeda Y, Fujiwara K, Tachibana T, Hisatomi T, Yoshida S, Ishibashi T, Nakabeppu Y, Sonoda KH; ARVO, Seattle,USA, 2016/05/02
27.Comparison of AO-SLO and OCT Angiography in Imaging of The Hierarchical Structure of Retinal Vessels Kaizu Y, Nakao S, Yamaguchi M, Kaizu M, Kobayashi Y, Nakama T, Yoshida S, Oshima Y, Ishibashi T, Sonoda KH; ARVO, Seattle,USA, 2016/05/01
28.Quantifying metamorphopsia using M-CHARTS in patients with idiopathic macular hole Wada I, Yoshida S, Kobayashi Y, Akiyama M, Koyanagi Y, Nakama T, Ishikawa K, Yamaguchi M, Nakao S, Oshima Y, Sonoda KH, Ishibashi T; ARVO, Seattle,USA, 2016/05/01
29.Therapeutic Potential of Topical ROCK Inhibitor Ripasudil (K-115) in Choroidal Neovasculaization Yamaguchi M, Nakao S, Kaizu Y, Kobayashi Y, Nakama T, Yoshida S, Oshima Y, Isobe T, Kaneko Y, Ishibashi T, Sonoda KH; ARVO, Seattle, USA, 2016/05/01
30.Interleukin-12 regulates ischemia-induced retinal neovascularization Zhou Yedi, Yoshida S, Nakao S, Kubo Y, Kobayashi Y, Nakama T, Yamaguchi M, Ishikawa K, Oshima Y, Ishibashi T, Sonoda KH; 第120回日本眼科学会, 宮城県, 2016/04/10
68.Seven cases with malignant lymphoma of the lacrimal sac region in Japanese 田邉美香, 吉川洋, 有田量一, 髙木健一, 藤川佳奈子, 園田康平; APSOPRS & JSOPRS Joint Meeting, 大阪府, 2016/08/26
1.alpha B Crystallin REGULATES SUBRETINAL FIBROSIS BY MODULATION OF EPITHELIAL-MESENCHYMAL TRANSITION Ishikawa K, David R. Hinton, Ram Kannan; XXII Biennial Meeting of the International Society for Eye Research Tokyou,Japan, 2016/09/27
2.Assessing the metamorphopsia before and after vitrectomy Yoshida S; The 3rd Kyushu-Beijing-Youngnam retina meeting symposium Beihai,China,, 2016/08/05
3.Gene Therapy for Inherited Retinal Degenerations Ikeda Y; Japan Society of Gene and Cell Therapy 2016 シンポジウム Tokyou,Japan, 2016/07/28
4.EYLEA in Management of PCV—Experiences from Japan Oshima Y; APAO 2016 ランチョン・イブニングセミナー Taipei,China, 2016/03/26
5.Therapeutic Challenge-Medical Treatment and Long Sonoda KH; APAO 2016 Instruction course‘Viral retinitis - an Taipei,China, 2016/03/25
6.Widefield Imaging in the Management of Diabetic Retinopathy Oshima Y; APAO 2016 Taipei,China, 2016/03/25
7.ROCK Inhibitor for Diabetic Retinopathy Nakao S; World Ophthalmology Congress 2016 Symposium Mexico,Mexico, 2016/02/08
8.Strategy to advance translational research in retinal vascular diseases 中尾新太郎; 第24回日本血管生物医学会学術集会 シンポジウム 長崎県, 2016/12/04
1.Anti-VEGF agents for the treatment of PCV Oshima Y; Bayer advisory board APVRS 2016 Bangkok,Thailand , 2016/12/10
2.Regenerative Medicine Business and Fukuoka Kagimoto T; Fukuoka International Business Association Fukuoka,Japan, 2016/10/26
3.The Possibility of Ultra High Resolution in 2 μm~Experence Reports in Using KOWA OCT Bi-μ~ Nakao S; Kowa Ultra High Resolution OCT Seminar Copenhagen,Danmark, 2016/09/10
4.Japan Session Kagimoto T; BIO2016 San Francisco, CA, USA, 2016/06/08
5.Spotlight on Japan: Lessons learnt from embarking on clinical trials & market authorization in Japan Kagimoto T; World Stem Cells & Regenerative Medicine Congress 2016 London, UK, 2016/05/19
6.MUTYH promotes oxidative microglial activation and neurodegeneration in a mouse model of retinitis pigmentosa Nakatake S, Murakami Y, Ikeda Y, Tachibana T, Hisatomi T, Yoshida S, Nakabeppu Y, Ishibashi T, Sonoda KH; All English Meeting Seattle, USA, 2016/05/01
7.JPモルガン・ヘルスケア・カンファレンス・プレゼンテーション Kagimoto T; JPモルガン・ヘルスケア・カンファレンス San Francisco, USA, 2016/01/11
8.AMDに伴う網膜化線維性瘢痕の病態メカニズム 石川桂二郎; Basic Research Integrative Meeting on Ophthalmology 東京都, 2016/12/18
